Your browser doesn't support javascript.
loading
Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study.
Baeten, Jared M; Palanee-Phillips, Thesla; Mgodi, Nyaradzo M; Mayo, Ashley J; Szydlo, Daniel W; Ramjee, Gita; Gati Mirembe, Brenda; Mhlanga, Felix; Hunidzarira, Portia; Mansoor, Leila E; Siva, Samantha; Govender, Vaneshree; Makanani, Bonus; Naidoo, Logashvari; Singh, Nishanta; Nair, Gonasagrie; Chinula, Lameck; Parikh, Urvi M; Mellors, John W; Balán, Iván C; Ngure, Kenneth; van der Straten, Ariane; Scheckter, Rachel; Garcia, Morgan; Peda, Melissa; Patterson, Karen; Livant, Edward; Bunge, Katherine; Singh, Devika; Jacobson, Cindy; Jiao, Yuqing; Hendrix, Craig W; Chirenje, Zvavahera M; Nakabiito, Clemensia; Taha, Taha E; Jones, Judith; Torjesen, Kristine; Nel, Annalene; Rosenberg, Zeda; Soto-Torres, Lydia E; Hillier, Sharon L; Brown, Elizabeth R.
Afiliação
  • Baeten JM; Department of Global Health, University of Washington, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA. Electronic address: jbaeten@uw.edu.
  • Palanee-Phillips T; Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Mgodi NM; University of Zimbabwe College of Health Sciences Clinical Trials Research Centre, Harare, Zimbabwe.
  • Mayo AJ; FHI 360, Durham, NC, USA.
  • Szydlo DW; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Ramjee G; HIV Prevention Research Unit, South African Medical Research Council, Durban, South Africa; Aurum Institute, Johannesburg, South Africa.
  • Gati Mirembe B; Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda.
  • Mhlanga F; University of Zimbabwe College of Health Sciences Clinical Trials Research Centre, Harare, Zimbabwe.
  • Hunidzarira P; University of Zimbabwe College of Health Sciences Clinical Trials Research Centre, Harare, Zimbabwe.
  • Mansoor LE; Centre for AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.
  • Siva S; HIV Prevention Research Unit, South African Medical Research Council, Durban, South Africa.
  • Govender V; HIV Prevention Research Unit, South African Medical Research Council, Durban, South Africa; Aurum Institute, Johannesburg, South Africa.
  • Makanani B; College of Medicine-Johns Hopkins Research Project, Queen Elizabeth Central Hospital, Blantyre, Malawi.
  • Naidoo L; HIV Prevention Research Unit, South African Medical Research Council, Durban, South Africa.
  • Singh N; HIV Prevention Research Unit, South African Medical Research Council, Durban, South Africa.
  • Nair G; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
  • Chinula L; University of North Carolina Project, Lilongwe, Malawi; Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC, USA.
  • Parikh UM; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Mellors JW; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Balán IC; HIV Center for Clinical and Behavioral Studies at New York State Psychiatric Institute and Columbia University, New York, NY, USA.
  • Ngure K; Department of Community Health, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.
  • van der Straten A; Women's Global Health Imperative, RTI International, San Francisco, CA, USA; Center for AIDS Prevention Studies, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Scheckter R; FHI 360, Durham, NC, USA.
  • Garcia M; FHI 360, Durham, NC, USA.
  • Peda M; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Patterson K; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Livant E; Magee-Womens Research Institute, Pittsburgh, PA, USA.
  • Bunge K; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA, USA.
  • Singh D; Magee-Womens Research Institute, Pittsburgh, PA, USA.
  • Jacobson C; Magee-Womens Research Institute, Pittsburgh, PA, USA.
  • Jiao Y; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Hendrix CW; Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
  • Chirenje ZM; University of Zimbabwe College of Health Sciences Clinical Trials Research Centre, Harare, Zimbabwe.
  • Nakabiito C; Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda.
  • Taha TE; College of Medicine-Johns Hopkins Research Project, Queen Elizabeth Central Hospital, Blantyre, Malawi; Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA.
  • Jones J; Magee-Womens Research Institute, Pittsburgh, PA, USA.
  • Torjesen K; FHI 360, Durham, NC, USA.
  • Nel A; International Partnership for Microbicides, Silver Spring, MD, USA.
  • Rosenberg Z; International Partnership for Microbicides, Silver Spring, MD, USA.
  • Soto-Torres LE; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Hillier SL; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA, USA.
  • Brown ER; Department of Biostatistics, University of Washington, Seattle, WA, USA; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Lancet HIV ; 8(2): e87-e95, 2021 02.
Article em En | MEDLINE | ID: mdl-33539762

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Infecções por HIV / Dispositivos Anticoncepcionais Femininos / Fármacos Anti-HIV / Tenofovir Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Female / Humans País/Região como assunto: Africa Idioma: En Revista: Lancet HIV Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Infecções por HIV / Dispositivos Anticoncepcionais Femininos / Fármacos Anti-HIV / Tenofovir Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Female / Humans País/Região como assunto: Africa Idioma: En Revista: Lancet HIV Ano de publicação: 2021 Tipo de documento: Article